4.6 Review Book Chapter

Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases

期刊

ANNUAL REVIEW OF GENETICS, VOL 52
卷 52, 期 -, 页码 271-293

出版社

ANNUAL REVIEWS
DOI: 10.1146/annurev-genet-120417-031534

关键词

aging; induced neurons; iNs; disease modeling; age-associated neurodegeneration; induced pluripotent stem cells; iPSCs; rejuvenation

资金

  1. NATIONAL INSTITUTE ON AGING [R01AG056306, K99AG056679] Funding Source: NIH RePORTER
  2. NIA NIH HHS [R01 AG056306, K99 AG056679] Funding Source: Medline

向作者/读者索取更多资源

Age-associated neurological diseases represent a profound challenge in biomedical research as we are still struggling to understand the interface between the aging process and the manifestation of disease. Various pathologies in the elderly do not directly result from genetic mutations, toxins, or infectious agents but are primarily driven by the many manifestations of biological aging. Therefore, the generation of appropriate model systems to study human aging in the nervous system demands new concepts that lie beyond transgenic and drug-induced models. Although access to viable human brain specimens is limited and induced pluripotent stem cell models face limitations due to reprogramming-associated cellular rejuvenation, the direct conversion of somatic cells into induced neurons allows for the generation of human neurons that capture many aspects of aging. Here, we review advances in exploring age-associated neurodegenerative diseases using human cell reprogramming models, and we discuss general concepts, promises, and limitations of the field.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Pathological priming causes developmental gene network heterochronicity in autistic subject-derived neurons

Simon T. Schafer, Apua C. M. Paquola, Shani Stern, David Gosselin, Manching Ku, Monique Pena, Thomas J. M. Kuret, Marvin Liyanage, Abed AlFatah Mansour, Baptiste N. Jaeger, Maria C. Marchetto, Christopher K. Glass, Jerome Mertens, Fred H. Gage

NATURE NEUROSCIENCE (2019)

Review Biochemistry & Molecular Biology

Next-generation disease modeling with direct conversion: a new path to old neurons

Larissa Traxler, Frank Edenhofer, Jerome Mertens

FEBS LETTERS (2019)

Review Biochemistry & Molecular Biology

Take the shortcut - direct conversion of somatic cells into induced neural stem cells and their biomedical applications

Anita Erharter, Sandra Rizzi, Jerome Mertens, Frank Edenhofer

FEBS LETTERS (2019)

Review Geriatrics & Gerontology

When function follows form: Nuclear compartment structure and the epigenetic landscape of the aging neuron

Johannes C. M. Schlachetzki, Tomohisa Toda, Jerome Mertens

EXPERIMENTAL GERONTOLOGY (2020)

Editorial Material Cell & Tissue Engineering

One Big Step to a Neuron, Two Small Steps for miRNAs

Joseph R. Herdy, Lukas Karbacher, Jerome Mertens

Summary: Researchers dissect the process of converting human somatic cells into iNs into two largely independent steps and identify key players in each stage.

CELL STEM CELL (2021)

Article Cell & Tissue Engineering

Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer's patients

Jerome Mertens, Joseph R. Herdy, Larissa Traxler, Simon T. Schafer, Johannes C. M. Schlachetzki, Lena Bohnke, Dylan A. Reid, Hyungjun Lee, Dina Zangwill, Diana P. Fernandes, Ravi K. Agarwal, Raffaella Lucciola, Lucia Zhou-Yang, Lukas Karbacher, Frank Edenhofer, Shani Stern, Steve Horvath, Apua C. M. Paquola, Christopher K. Glass, Shauna H. Yuan, Manching Ku, Attila Szucs, Lawrence S. B. Goldstein, Douglas Galasko, Fred H. Gage

Summary: Our study identifies AD-related neuronal changes as age-dependent cellular programs that impair neuronal identity.

CELL STEM CELL (2021)

Review Cell Biology

Metabolism navigates neural cell fate in development, aging and neurodegeneration

Larissa Traxler, Jessica Lagerwall, Sophie Eichhorner, Davide Stefanoni, Angelo D'Alessandro, Jerome Mertens

Summary: An uninterrupted energy supply is crucial for the optimal functioning of all organs, particularly the human brain which is highly energy dependent. Research in neuroscience focuses on energy metabolic pathways, as genetic defects in oxidative phosphorylation mechanism contribute towards neurodevelopmental disorders and changes in glucose metabolism are observed in neurodegenerative disorders. Recent studies have shown that metabolism plays a vital role in cell fate and function, impacting diseases of the brain.

DISEASE MODELS & MECHANISMS (2021)

Article Cell Biology

Improved Method for Efficient Generation of Functional Neurons from Murine Neural Progenitor Cells

Abhinav Soni, Diana Kluetsch, Xin Hu, Judith Houtman, Nicole Rund, Asako McCloskey, Jerome Mertens, Simon T. Schafer, Hayder Amin, Tomohisa Toda

Summary: The study employed a method combining neural stem cell culture and direct cell type conversion to efficiently generate functional neurons, offering opportunities for investigating plasticity mechanisms, drug screening assays, and probing the molecular and biophysical basis of neurodevelopmental and neurodegenerative diseases.
Article Cell & Tissue Engineering

Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion

Lena Boehnke, Lucia Zhou-Yang, Silvia Pelucchi, Flora Kogler, Daniela Frantal, Florian Schoen, Stina Lagerstroem, Oliver Borgogno, Jennifer Baltazar, Joseph R. Herdy, Sarah Kittel-Schneider, Michaela Defrancesco, Jerome Mertens

Summary: Direct conversion of human skin fibroblasts into induced neurons is a useful technology for generating donor-specific human neurons. Researchers have identified ALK2 as a potential replacement for recombinant Noggin, which is commonly used in the conversion protocol. The ALK2 inhibitor DMH1 enhances conversion efficiency and yields high-purity neuronal cultures at a lower cost compared to traditional methods.

CELLULAR REPROGRAMMING (2022)

Article Cell Biology

Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer's disease

Larissa Traxler, Joseph R. Herdy, Davide Stefanoni, Sophie Eichhorner, Silvia Pelucchi, Attila Szucs, Alice Santagostino, Yongsung Kim, Ravi K. Agarwal, Johannes C. M. Schlachetzki, Christopher K. Glass, Jessica Lagerwall, Douglas Galasko, Fred H. Gage, Angelo D'Alessandro, Jerome Mertens

Summary: This study investigated the metabolic changes and transcriptional alterations in sporadic Alzheimer's disease (AD) utilizing induced neurons (iNs) from AD patients. The pathological isoform switching of PKM2 was found to contribute to neuronal vulnerability and loss in AD. Chemical modulation of PKM2 could reverse these changes and enhance neuronal resilience against cell death.

CELL METABOLISM (2022)

Article Neurosciences

Druggable transcriptomic pathways revealed in Parkinson's patient-derived midbrain neurons

Mark van den Hurk, Shong Lau, Maria C. Marchetto, Jerome Mertens, Shani Stern, Olga Corti, Alexis Brice, Beate Winner, Juergen Winkler, Fred H. Gage, Cedric Bardy

Summary: This study investigated the gene dysregulation in live midbrain neurons reprogrammed from the skin cells of Parkinson's disease (PD) patients. The results showed dysregulation of genes involved in synaptic transmission, metabolism, and cellular stress/immune responses in PD. The study also identified pesticides and endoplasmic reticulum stressors as significant gene-chemical interactions in PD. Additionally, the researchers associated the PD transcriptomic profile with candidate pharmaceuticals in a large database and clinical trials registry.

NPJ PARKINSONS DISEASE (2022)

Article Cell & Tissue Engineering

Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer's disease

Joseph R. Herdy, Larissa Traxler, Ravi K. Agarwal, Lukas Karbacher, Johannes C. M. Schlachetzki, Lena Boehnke, Dina Zangwill, Doug Galasko, Christopher K. Glass, Jerome Mertens, Fred H. Gage

Summary: The concept of senescence extends beyond proliferating cells, as senescence-like features have been observed in neurons, including those affected by Alzheimer's disease. Targeting senescent neurons could be a strategy for preventing or treating AD.

CELL STEM CELL (2022)

Review Pharmacology & Pharmacy

Novel therapeutic approaches to target neurodegeneration

Alerie G. de la Fuente, Silvia Pelucchi, Jerome Mertens, Monica Di Luca, Daniela Mauceri, Elena Marcello

Summary: Ageing is the main risk factor for most primary neurodegenerative disorders, and protein misfolding and toxic protein accumulation are considered causative events. However, other biological pathways affected by brain ageing also contribute to pathogenesis. This article discusses the involvement of mechanisms controlling neuronal structure, gene expression, autophagy, cell metabolism, and neuroinflammation in the onset and progression of neurodegenerative disorders, and reviews therapeutic strategies aiming to normalize these pathways for increased brain resilience.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Review Clinical Neurology

Neural cell state shifts and fate loss in ageing and age-related diseases

Larissa Traxler, Raffaella Lucciola, Joseph R. R. Herdy, Jeffrey R. R. Jones, Jerome Mertens, Fred H. H. Gage

Summary: Most age-related neurodegenerative diseases remain incurable due to an incomplete understanding of the disease mechanisms. Cellular state shifts play an important role in sustaining the function and resilience of the young brain, but excessive state shifts in the aged brain might lead to pathological fate loss and neurodegeneration.

NATURE REVIEWS NEUROLOGY (2023)

Article Cell Biology

Obatoclax Rescues FUS-ALS Phenotypes in iPSC-Derived Neurons by Inducing Autophagy

Cristina Marisol Castillo Bautista, Kristin Eismann, Marc Gentzel, Silvia Pelucchi, Jerome Mertens, Hannah E. Walters, Maximina H. Yun, Jared Sterneckert

Summary: Aging disrupts protein homeostasis and contributes to various diseases, including ALS. Repressing autophagy is a strategy to restore protein homeostasis and protect neurons. A study found that obatoclax, a small molecule BH3 mimetic, can disrupt the interaction between BECN1 and BCL2, reducing FUS levels and improving protein homeostasis to rescue neurons. Obatoclax has potential as a therapeutic for ALS and other age-related disorders linked to protein homeostasis defects.
暂无数据